Active, not recruitingNot applicableNCT06422494

The Role of the Adrenergic System in Hypoglycaemia Induced Inflammatory Response in People With Type 1 Diabetes and People Without Type 1 Diabetes-RAID-II

Studying Combined immunodeficiency due to RELA haploinsufficiency

Last synced from ClinicalTrials.gov May 6, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Radboud University Medical Center
Principal Investigator: Cees Tack, MD, PhD
Radboud University Medical Center (Radboudumc)
Intervention: hyperinsulinaemic hypoglycaemic clamp(drug)
Enrollment: 24 enrolled
Eligibility: 16-75 years · All sexes
Timeline: 2025 – 2025

Study locations (1)

Radboud University Medical Center, Nijmegen, Netherlands, Nijmegen, Gelderland, Netherlands

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06422494 on ClinicalTrials.gov

← Back to all trials